Does the clinical practice guideline on Parkinson’s disease change health outcomes? A cluster randomized controlled trial

Author： Larisch Astrid Reuss Alexander Oertel Wolfgang Eggert Karla

Publisher： Springer Publishing Company

ISSN： 0340-5354

Source： Journal of Neurology, Vol.258, Iss.5, 2011-05, pp. : 826-834

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intravenous amantadine on freezing of gait in Parkinson’s disease: a randomized controlled trial

By Lee Jee Oh Sohee Kim Jong Kim Ji Oh Eungseok Kim Hee-Tae Jeon Beom Cho Jin

Journal of Neurology, Vol. 260, Iss. 12, 2013-12 ,pp. : 3030-3038

Springer Publishing Company

Access to resources Recommend Favorite

GDNF treatment in Parkinson’s disease: time for controlled clinical trials?

By Brundin Patrik

Brain, Vol. 125, Iss. 10, 2002-10 ,pp. : 2149-2151

Oxford University Press

Access to resources Recommend Favorite

Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson’s disease

By Stocchi F.

Brain, Vol. 125, Iss. 9, 2002-09 ,pp. : 2058-2066

Oxford University Press

Access to resources Recommend Favorite

Clinical heterogeneity in newly diagnosed Parkinson’s disease

By Post B. Speelman J. Haan R.

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 716-722

Springer Publishing Company

Access to resources Recommend Favorite

Parkinson’s disease: clinical manifestations and treatment

By Dawson Ted M.

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 263-269

Informa Healthcare

Access to resources Recommend Favorite